R&G PharmaStudies Dividend
Dividend criteria checks 2/6
R&G PharmaStudies is a dividend paying company with a current yield of 0.52% that is well covered by earnings.
Key information
0.5%
Dividend yield
12%
Payout ratio
| Industry average yield | 1.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.200 |
| Earnings per share | CN¥1.41 |
| Dividend yield forecast | 0.6% |
Recent dividend updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Too early to tell whether 301333's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if 301333's dividend payments are increasing as they only just started paying a dividend.
Dividend Yield vs Market
| R&G PharmaStudies Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (301333) | 0.5% |
| Market Bottom 25% (CN) | 0.8% |
| Market Top 25% (CN) | 2.8% |
| Industry Average (Life Sciences) | 1.7% |
| Analyst forecast (301333) (up to 3 years) | 0.6% |
Notable Dividend: 301333's dividend (0.52%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.75%).
High Dividend: 301333's dividend (0.52%) is low compared to the top 25% of dividend payers in the CN market (2.75%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (11.6%), 301333's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (9.9%), 301333's dividend payments are thoroughly covered by cash flows.